Skip to main content
background gradient

Volume 13Issue 10

Editorial

Open Access
How pharma can amplify product value with implementation science
  • Melvin (Skip) Olson,
  • Leah L Zullig, and
  • Sabina De Geest
e240076
Published Online:6 September 2024
Preview Abstract
Open Access
Why is the market design for innovative pharmaceuticals not well understood?
  • Francisco Olivença,
  • Jose Diaz,
  • Sreeram V Ramagopalan, and
  • Louis P Garrison
e240105
Published Online:10 September 2024

Protocol

Open Access
A clinical decision support tool for metabolic dysfunction-associated steatohepatitis in real-world clinical settings: a mixed-method implementation research study protocol
  • Jesse Fishman,
  • Theresa Alexander,
  • Yestle Kim,
  • Iris Kindt, and
  • Patricia Mendez
e240085
Published Online:20 September 2024
Preview Abstract

Short Report

Open Access
Comparative efficacy of diroximel fumarate, ozanimod and interferon beta-1a for relapsing multiple sclerosis using matching-adjusted indirect comparisons
  • Tammy Jiang,
  • Mathura Shanmugasundaram,
  • Ivan Božin,
  • Mark S Freedman,
  • James B Lewin,
  • Changyu Shen,
  • Tjalf Ziemssen, and
  • Douglas L Arnold
e230161
Published Online:19 August 2024
Preview Abstract

Research Article

Open Access
One-year budget impact of InTandem™: a novel neurorehabilitation system for individuals with chronic stroke walking impairment
  • Kirsten E Smayda,
  • Jennifer Lavanture,
  • Megan Bourque,
  • Nathashi Jayawardena,
  • Sarah Kane,
  • Holly Roberts, and
  • Barbara Heikens
e240010
Published Online:3 September 2024
Preview Abstract
Open Access
An international observational study assessing conservative management in hemorrhoidal disease: results of CHORALIS (aCute HemORrhoidal disease evALuation International Study)
  • Philippe Godeberge,
  • Zoltan Csiki,
  • Mykhailo Zakharash,
  • Elly Nyaim Opot,
  • Yuri A Shelygin,
  • Trung Tin Nguyen,
  • Ashraf Amir,
  • Ibrahima Konaté,
  • Moses Momoh,
  • Joanna Chirol,
  • Vanessa Blanc-Guillemaud, and
  • Ren Donglin
e240070
Published Online:12 August 2024
Preview Abstract
Open Access
Comparing the efficacy of cipaglucosidase alfa plus miglustat with other enzyme replacement therapies for late-onset Pompe disease: a network meta-analysis utilizing patient-level and aggregate data
  • Simon Shohet,
  • Noemi Hummel,
  • Shuai Fu,
  • Ian Keyzor,
  • Alasdair MacCulloch,
  • Neil Johnson,
  • Jeff Castelli,
  • Ilona Czarny-Ozga,
  • Tahseen Mozaffar, and
  • Howard Thom
e240045
Published Online:17 September 2024
Preview Abstract

Systematic Review

Open Access
A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib
  • Imtiaz A Samjoo,
  • Alexandra Hall,
  • Connie Chen,
  • Bao-Ngoc Nguyen,
  • Meaghan Bartlett,
  • Mary Lou Smith,
  • Nadia Harbeck,
  • Joseph C Cappelleri,
  • Meghan Karuturi,
  • Doris Makari,
  • Lillian Shahied Arruda,
  • Rickard Sandin,
  • Kent Hanson, and
  • Justin Doan
e240111
Published Online:10 September 2024
Preview Abstract